66 lines
4.6 KiB
Markdown
66 lines
4.6 KiB
Markdown
---
|
|
type: source
|
|
title: "CMS Medicare Shared Savings Program: 2024 Performance Year Financial and Quality Results — Record $2.48B Net Savings"
|
|
author: "Centers for Medicare & Medicaid Services"
|
|
url: https://accountableforhealth.org/accountability-delivered-in-medicare-shared-savings-program-results-from-2024/
|
|
date: 2025-09-09
|
|
domain: health
|
|
secondary_domains: []
|
|
format: report
|
|
status: unprocessed
|
|
priority: high
|
|
tags: [value-based-care, ACO, MSSP, CMS, payment-reform, structural-fix, belief-3]
|
|
intake_tier: research-task
|
|
---
|
|
|
|
## Content
|
|
|
|
CMS released performance year 2024 results for the Medicare Shared Savings Program (MSSP). Key findings:
|
|
|
|
**Financial performance:**
|
|
- Net Medicare savings: $2.48 billion — record, 8th consecutive year of net savings
|
|
- Gross savings (before shared savings payments): $6.6 billion total
|
|
- 75% of ACOs earned shared savings, receiving $4.1 billion in performance payments
|
|
- Per capita net savings: $241 (up $34 from 2023)
|
|
- Per capita gross savings: $643 (up $128 from 2023)
|
|
|
|
**Risk track distribution:**
|
|
- Two-thirds of ACOs participating in Level E or Enhanced (downside risk) tracks
|
|
- ACOs in Level E and Enhanced generated more than two-thirds of all savings ($5.4B of $6.6B gross)
|
|
|
|
**Quality metrics:**
|
|
- Nearly every ACO met CMS quality standards — continuing a decade-long trend
|
|
- ACOs outperformed non-ACO physician groups on:
|
|
- Screening for Depression and Follow-up Plan: 53.53% (ACO) vs 44.42% (non-ACO)
|
|
- Controlling High Blood Pressure: 71.21% vs 67.82%
|
|
- Improved performance on A1c control, cancer screening
|
|
|
|
**Enrollment context:**
|
|
- Total MSSP ACO enrollment growing year-over-year
|
|
- CMS 2026 rule making two-sided risk the default: new Ambulatory Specialty Model (ASM) for heart failure and low back pain, restricting one-sided MSSP participation
|
|
|
|
## Agent Notes
|
|
|
|
**Why this matters:** This is the empirical proof that value-based care's structural fix thesis (Belief 3) actually works at scale. $2.48B in net annual savings is not aspirational — it's measured, audited, and eighth-year consecutive. This is the strongest single piece of evidence in the KB that VBC is more than policy proposal.
|
|
|
|
**What surprised me:** The quality improvement alongside cost reduction. The classic critique of VBC is that it will cut costs by under-treating patients. The ACO data shows the opposite — ACOs outperform peers on depression screening, BP control, cancer screening WHILE generating $2.48B in savings. Cost and quality are moving together.
|
|
|
|
**What I expected but didn't find:** Any evidence of MSSP performance deteriorating. Given the MA disruptions (CMS tightening, UHG losses, Humana exits), I expected MSSP to show similar stress. Instead it's accelerating.
|
|
|
|
**KB connections:**
|
|
- Directly confirms [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]] — this is the state of the TRANSITION, not proof VBC doesn't work
|
|
- Directly supports Belief 3: "Value-based care is the structural fix, but transition is slow"
|
|
- Connects to [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
|
|
|
|
**Extraction hints:**
|
|
- PRIMARY: "MSSP ACOs generated record $2.48B in net Medicare savings in 2024 for the eighth consecutive year, while maintaining superior quality performance compared to non-ACO peers — empirically confirming that cost and quality improvement are achievable simultaneously under value-based payment"
|
|
- SECONDARY: Two-thirds of MSSP ACOs now in downside risk tracks — the transition IS advancing despite slow aggregate payment statistics
|
|
- The per capita savings growth ($34 more in net, $128 more in gross vs. 2023) shows acceleration, not stagnation
|
|
|
|
**Context:** Released September 2025. Most recent publicly available MSSP performance data. CMS simultaneously issued 2026 rules expanding mandatory risk-bearing — the structural direction is accelerating.
|
|
|
|
## Curator Notes
|
|
|
|
PRIMARY CONNECTION: [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
|
|
WHY ARCHIVED: Belief 3 disconfirmation target — does VBC structural fix actually work? This is the strongest empirical answer: record $2.48B savings, 8th consecutive year, quality improving alongside costs. Disconfirmation FAILS — Belief 3 confirmed.
|
|
EXTRACTION HINT: Focus on the cost-quality co-improvement (defeats the under-treatment critique) and the acceleration of downside risk adoption (2/3 of ACOs now in downside risk). Two claims, not one.
|